Results for tag: metastatic breast cancer Total Items Found: 20

Ian Krop on Trastuzumab Deruxtecan for Previously Treated HER2-Positive Metastatic Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
adc
t-dxd
trastuzumab emtansine
HER2-positive
metastatic breast cancer
san antonio breast
t-dm1
trastuzumab deruxtecan

Created: 12/13/2019 8:45:34 PM

Hope Rugo on SOPHIA Trial of Chemotherapy Plus Margetuximab or Trastuzumab

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast
HER2-positive
metastatic breast cancer
sophia trial
margetuximab
chemotherapy
trastuzumab
immunotherapy

Created: 12/13/2019 8:16:30 PM

Joseph Sparano: The William L. McGuire Memorial Lecture

Type of Page:TapVideo
Edit This Item
Tags for this item:
adjuvant therapy
mcguire lecture
systemic therapy
active cancer surveillance
breast cancer
diagnostics
gene expression
metastatic breast cancer
molecular testing
san antonio breast

Created: 12/13/2019 8:03:00 PM

Tari King on Molecular Differences Between Primary and Metastatic Breast Tumors

Type of Page:TapVideo
Edit This Item
Tags for this item:
mbc
breast cancer
metastatic breast cancer
metastatic tumors
molecular
primary tumors
San Antonio Breast

Created: 12/13/2019 6:59:22 PM

Sibylle Loibl on Metastatic Breast Cancer Research Highlights

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2018
breast cancer
metastatic breast cancer
triple-negative breast cancer
IMpower 130
PALOMA3
SOLAR-1
hormone receptor positive
HER2 negative

Created: 10/21/2018 10:45:23 AM

Eric S. Winer, MD, on Metastatic Breast Cancer: Debate on a Research Tool

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
metastatic breast cancer
next-generation sequencing
NGS

Created: 12/8/2017 5:10:01 PM

Sibylle Loibl, MD, PhD, on Metastatic Breast Cancer: the PADMA Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
metastatic breast cancer
breast cancer
PADMA trial
palbociclib
endocrine treatment
chemotherapy
hormone receptor–positive
HER2-negative

Created: 12/8/2017 5:08:24 PM

Lynn J. Howie, MD, on ER+ Metastatic Breast Cancer: An FDA Treatment Analysis

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
ER+ breast cancer
metastatic breast cancer
breast cancer
CDK4/6 inhibitor
endocrine-based therapy
initial therapy

Created: 12/8/2017 4:56:27 PM

Lisa A. Carey, MD, on Locally Recurrent or Metastatic Breast Cancer: Results of a CALGB/NCCTG Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
locally recurrent breast cancer
metastatic breast cancer
CALGB 40502
NCCTG N063H
paclitaxel
nab-paclitaxel
ixabepilone
bevacizumab
breast cancer

Created: 12/7/2017 5:57:38 PM

Sherene Loi, MD, PhD, and Roberto Salgado, MD, PhD, on HER2+ Metastatic Breast Cancer: Results From the PANACEA/KEYNOTE 014 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
HER2+ breast cancer
metastatic breast cancer
PANACEA
KEYNOTE 014
pembrolizumab
trastuzumab
trastuzumab-resistant disease

Created: 12/7/2017 12:28:36 PM

Sibylle Loibl, MD, PhD, on Metastatic Breast Cancer: Expert Perspective on CDK4 Inhibitors

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2017
Sibylle Loibl
German Breast Group
metastatic breast cancer
breast cancer
CDK4 inhibitor
PI3K

Created: 9/11/2017 2:28:29 AM

Ruth O'Regan, MD, on Locally Advanced and Metastatic Breast Cancer: Results of the BELLE-3 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast
Ruth O'Regan
University of Wisconsin
BELLE-3 trial
locally advanced breast cancer
metastatic breast cancer
buparlisib
fulvestrant
postmenopausal
HR+/HER2+
aromatase inhibitor
mTOR inhibitor

Created: 12/9/2016 4:03:19 PM

Hyo Sook Han, MD, on Metastatic Breast Cancer: Trial Results on Veliparib, Carboplatin, and Paclitaxel

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
Heather Sook Han
Moffitt Cancer Center
metastatic breast cancer
veliparib
carboplatin
paclitaxel
BRCA1
BRCA2
San Antonio Breast

Created: 12/9/2016 3:11:31 PM

Judith Balmaña, MD, PhD, on Metastatic Breast Cancer: Study Results on Lurbinectedin (Spanish Language Version)

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Judith Balmana
Vall d'Hebron University Hospita
metastatic breast cancer
breast cancer
lurbinectedin
BRCA1
BRCA2

Created: 10/17/2016 1:56:35 PM

Judith Balmaña, MD, PhD, on Metastatic Breast Cancer: Study Results on Lurbinectedin

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Judith Balmana
Vall d'Hebron University Hospita
metastatic breast cancer
breast cancer
lurbinectedin
BRCA1
BRCA2

Created: 10/10/2016 6:09:15 AM

Lisa A. Carey, MD, and Nicholas C. Turner, MD, PhD, on PALOMA-2 and -3 Study Findings in Advanced Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2016
Lisa Carey
ESR1 mutation
University of North Carolina
The Royal Marsden
Nicholas Turner
metastatic breast cancer
palbociclib
fulvestrant
endocrine resistance
circulating tumor DNA
PALOMA
ER+/HER2–
letrozole

Created: 6/9/2016 2:43:23 PM

William Gradishar, MD, on Breast Cancer Guideline Updates

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 NCCN Annual Meeting
William Gradishar
Northwestern University
breast cancer
HER2-directed therapy
adjuvant endocrine treatment
premenopausal breast cancer
Robert H. Lurie
estrogen receptor-positive
metastatic breast cancer

Created: 4/4/2016 10:36:40 AM

Ingrid Mayer MD on New Therapies Hormone-Sensitive Advanced Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN
Ingrid Mayer
metastatic breast cancer
endocrine therapy
everolimus

Created: 1/31/2016 9:17:05 AM

Nicholas C. Turner, MD, PhD, and Clifford A. Hudis, MD, on Results of the PALOMA3 Study on Hormone Receptor–Positive, HER2 Negative Metastatic Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2015
Nicholas Turner
Royal Marsden
Cliff Hudis
Memorial Sloan Kettering
PALOMA3
palbociclib
HR positive
HER2 negative
metastatic breast cancer
febrile neutropenia
CDK46
aromatase inhibitors
fulvestrant

Created: 1/31/2016 9:07:32 AM

Jame Abraham, MD, on The JAVELIN and KEYNOTE-028 Study Results

Type of Page:TapVideo
Edit This Item
Tags for this item:
SABCS 2015
Jame Abraham
Cleveland Clinic
locally advanced breast cancer
metastatic breast cancer
JAVELIN study
KEYNOTE-028 study
avelumab
anti-PD-L1 antibody
pembrolizumab
PD-L1-positive
estrogen receptor-positive
HER2-negative
breast cancer

Created: 12/24/2015 12:40:28 PM
Order By Item Count
Order Alphabetically